Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2013 Feb 23;71(5):1173–1182. doi: 10.1007/s00280-013-2109-x

Table 2.

Hematological and non-hematological toxicities grade 2 and higher (cycle 1 and all cycles) at least possibly related to therapy: phase I part of study

AE_NAME DL 30 mcg/m2
(n = 5)
DL 45 mcg/m2
(n = 3)
DL 60 mcg/m2
(n = 6)
DL 80 mcg/m2
(n = 4)
Cycle 1
Death 1 0 0 0
Dehydration grade 3/4 1 0 0 1
Diarrhea grade 2/3 0 0 2 1
Fatigue grade 2 0 0 3 1
Fatigue grade 3 0 0 0 1
Hypocalcemia grade 2/3 1 0 2 0
Hyponatremia grade 3 1 0 1 0
Hypophosphatemia grade 3 0 0 1 0
Hypotension grade 2/3 0 1 1 0
Hypotension grade 4 1 0 0 0
Muscle weakness grade 3 0 0 0 1
Neutropenia grade 2 2 2 0 0
Neutropenia grade 3 1 0 1 0
Neutropenia grade 4 1 1 1 2
Febrile neutropenia 1 0 0 0
Thrombosis grade 3 0 0 1 2
All cycles
Dehydration grade 2/3 1 0 1 2
Dehydration grade 4 1 0 0 0
Diarrhea grade 2/3 0 0 2 1
Fatigue grade 2/3 0 1 5 2
Hypocalcemia grade 2/3 1 0 2 0
Hyponatremia grade 3 1 0 1 0
Hypophosphatemia grade 2 0 1 1 0
Hypophosphatemia grade 3 0 0 1 0
Hypotension grade 3 0 0 2 0
Infection grade 3 0 0 1 0
Infection grade 5 1 0 0 0
Nausea grade 3 0 0 0 1
Neutropenia grade 2 2 2 1 0
Neutropenia grade 3 2 0 1 0
Neutropenia grade 4 1 1 1 2
Febrile neutropenia 2 1 0 0
Neuropathy grade 2 1 0 1 0
Pain grade 2 1 0 0 1
Pulmonary embolus grade 4 1 0 0 0
Thrombosis grade 3 0 0 0 1
Vomiting grade 3 0 0 1 0